On 5 July 2025, OpenAI co-founder Greg Brockman revealed that ChatGPT is being used to tackle complex medical problems once thought unsolvable. What began as a conversational AI is now moving into hard-science territory—supporting clinicians in diagnostics, rare-disease detection, and treatment planning. The implications are enormous. With global healthcare valued